COVID-19 is an emerging, rapidly evolving situation.
COVID-19 public health info from US CDC | COVID-19 research info from the US NIH | COVID-19 resources for global health researchers
Global health news briefs - February 2020
January / February 2020 | Volume 19, Number 1
Analysis of research in higher ed released
WHO has published a study of data from higher education institutions in 178 countries that offer disciplines related to health research training. The information allows users to examine available capacity, as well as gaps in teaching and training opportunities, and to monitor progress over time.
Ethics issues studied for research in crises
Better evidence about what works during global health emergencies is needed but gathering it poses a number of ethical challenges. A new report published by the Nuffield Council on Bioethics examines issues such as study design, collaborations and sample gathering. Several Fogarty staff contributed to the effort.
CDC publishes global health security tips
A new report shares lessons learned from CDC and partners’ work to help countries build core public health capacities to quickly identify and address health threats at their source. Articles highlight the value of effective partnerships, and the link between local and global health.
G-FINDER report finds uneven progress
The twelfth annual G-FINDER report has been released, providing data on investments made on neglected disease research and development in 2018. In all, 262 organizations completed the survey, which covered 36 neglected diseases, all relevant product types and basic research.
GHTC develops new fact sheets
The Global Health Technologies Coalition has unveiled a new fact sheet series that examines the role of research and development in driving progress across diseases and topics, including HIV/AIDS, malaria, TB, neglected tropical diseases, emerging infectious diseases and child health.
Many researchers fail to report results
A study of data in ClinicalTrials.gov published in
The Lancet showed fewer than half of all trials are in full compliance with FDA regulations to report results within one year. By examining 4,209 registered trials, the authors found nearly 64% had reported some results but only 40% were fully compliant.
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.